Search Results - "Abdelfadiel, Elsamani I."
-
1
A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation
Published in Molecular cancer therapeutics (01-01-2019)“…Targeting of cancer stem cells (CSC) is expected to be a paradigm-shifting approach for the treatment of cancers. Cell surface proteoglycans bearing sulfated…”
Get full text
Journal Article -
2
Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors
Published in Journal of medicinal chemistry (13-04-2023)“…Natural glycosaminoglycans (GAGs) are arguably the most diverse collection of natural products. Unfortunately, this bounty of structures remains untapped…”
Get full text
Journal Article -
3
Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity
Published in Journal of medicinal chemistry (26-01-2023)“…Sulfated glycosaminoglycans (GAGs), or synthetic mimetics thereof, are not favorably viewed as orally bioavailable drugs owing to their high number of anionic…”
Get full text
Journal Article -
4
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding
Published in Journal of thrombosis and haemostasis (01-12-2019)“…Background Human factor XIa (FXIa) is an actively pursued target for development of safer anticoagulants. Our long‐standing hypothesis has been that…”
Get full text
Journal Article -
5
518 - G2.2, a Unique Non-Sachharide Mimetic of Heparin Hexasaccharide Selectively Inhibits Cancerous but Protects Adult Colonic Stem/Progenitor Cells via a Common Mechanism of Induction of P38 Mitogen-Activated Protein Kinase
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2018)Get full text
Journal Article -
6
A Unique Non-Saccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation
Published in Molecular cancer therapeutics (18-10-2018)“…Targeting of cancer stem cells (CSCs) is expected to be a paradigm-shifting approach for the treatment of cancers. Cell surface proteoglycans bearing sulfated…”
Get full text
Journal Article